Effects of Rapamycin and Donor-Specific Transfusions on Activation-Induced Cell Death (AICD) and the Induction of Tolerance to Cardiac Allografts in Miniature Swine
Effects of Rapamycin and Donor-Specific Transfusions on Activation-Induced Cell Death (AICD) and the Induction of Tolerance to Cardiac Allografts in Miniature Swine
批准号:
5410310
负责人:
Dr. Rüdiger Hörbelt
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2003
资助国家:
德国
项目状态:
已结题
起止时间:
2002-12-31 至 2003-12-31
中文摘要
目前同种异体移植排斥反应的治疗需要广泛的慢性免疫抑制,这与使人衰弱的药物特异性副作用、感染、癌症和慢性排斥反应有关。克服这些问题的最佳方法是诱导宿主对供体异体抗原的特异性耐受。这将允许移植器官在没有免疫抑制的情况下长期接受,同时保持宿主抵抗感染和恶性肿瘤的能力。已经确定,特异性识别移植同种异体抗原的T细胞负责急性排斥反应,它们也有助于慢性同种异体移植排斥反应。先前的动物研究数据表明,多种T细胞相关机制参与了耐受性的诱导。根据最近的啮齿动物数据,通过激活诱导细胞死亡(AICD)删除大同种异体反应性T细胞库是稳定耐受性所必需的。然而,这一发现尚未在大型动物系统中得到证实。本研究的目的是验证一种假设,即促进AICD将允许在主要组织相容性复合体(MHC)近交系微型猪中诱导对心脏同种异体移植物的耐受。我们将使用高剂量的供者特异性输注结合短疗程的雷帕霉素来诱导同种异体反应性T细胞池的AICD。通过这种策略诱导快速和稳定的耐受性将具有重要的临床意义。
英文摘要
Current treatment for allograft rejection requires generalized, chronic immunosuppression, which is associated with debilitating drug-specific side effects, infection, cancer and chronic rejection. The optimal way to overcome all these problems is to induce specific tolerance to donor alloantigens in the host. This would allow long-term acceptance of transplanted organs without immunosuppression, and at the same time preserve the host's ability to fight infection and malignancy. It has been established that T cells that specifically recognize the transplanted alloantigen are responsible for acute rejection and that they also contribute to chronic allograft rejection. Data emerging from prior animal studies indicate that multiple T cell-related mechanisms are involved in the induction of tolerance. According to recent rodent data, deletion of the large alloreactive T cell pool by activation induced cell death (AICD) is necessary for stable tolerance. However, this finding has not been established in a large animal system. The aim of this study is test the hypothesis that facilitating AICD will permit the induction of tolerance to a cardiac allograft in major histocompatibility complex (MHC) inbred miniature swine. We will use high dose donor specific transfusions combined with a short course of rapamycin to induce AICD of the alloreactive T cell pool. The induction of rapid and stable tolerance via this strategy would have important clinical implications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Rapamycin引起雄性不育和mTOR信号通路调控精子发生的分子机制研究
-
批准号:81471502
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2014
-
负责人:叶岚
-
依托单位:
Akt抑制剂MK-2206和Rapamycin联合应用治疗神经母细胞瘤产生协同效应的机制研究
-
批准号:81472359
-
项目类别:面上项目
-
资助金额:72.0万元
-
批准年份:2014
-
负责人:李志杰
-
依托单位:
rapamycin诱导血管内皮、平滑肌细胞自噬的蛋白质组学研究
-
批准号:81300151
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:刘少军
-
依托单位:
HMGB1在Flt3L联合Rapamycin诱导移植免疫耐受的特征与机制
-
批准号:81373167
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:方敏
-
依托单位:
mTOR分子靶向药物Rapamycin对干细胞样肝癌细胞的作用研究
-
批准号:81000962
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:胡晨
-
依托单位: